BACKGROUND: The aim of this study was to investigate early morphological and functional pathology in the retinal micro-circulation in patients with insulin resistance and/or type 2 diabetes mellitus (T2DM). METHODS: Fifty-four subjects, without features of retinopathy under ophthalmological investigation, were recruited for study participation and were classified into three study groups according to their metabolic staging: (1) Group C comprised nondiabetic, insulin-sensitive subjects with a BMI <28 kg/m(2); (2) Group IR comprised nondiabetic, insulin-resistant, obese subjects with a BMI ≥28 kg/m(2); and (3) Group DM comprised patients with manifested T2DM. Retinal microvascular blood flow was assessed using scanning laser doppler flowmetry (Heidelberg Retina Flowmeter) before and after flicker light stimulation (10 Hz; Photo Stimulater 750). RESULTS: No significant difference was observed in retinal blood flow (RBF) among the three groups, neither at baseline nor after stimulating the retina with flicker light. The arterial wall-to-lumen ratio (WLR) tended to be smaller in Group DM compared with Group C, and was significantly lower when comparing Group IR with Group C. When the subjects were grouped according to their insulin resistance, a steady decline in RBF and WLR could be observed with increasing insulin resistance. CONCLUSIONS: In conclusion, laser scanner flowmetry of the retina was found to detect very early changes in microvascular blood flow. Development of insulin resistance seems to be an important component in the deterioration of RBF.
BACKGROUND: The aim of this study was to investigate early morphological and functional pathology in the retinal micro-circulation in patients with insulin resistance and/or type 2 diabetes mellitus (T2DM). METHODS: Fifty-four subjects, without features of retinopathy under ophthalmological investigation, were recruited for study participation and were classified into three study groups according to their metabolic staging: (1) Group C comprised nondiabetic, insulin-sensitive subjects with a BMI <28 kg/m(2); (2) Group IR comprised nondiabetic, insulin-resistant, obese subjects with a BMI ≥28 kg/m(2); and (3) Group DM comprised patients with manifested T2DM. Retinal microvascular blood flow was assessed using scanning laser doppler flowmetry (Heidelberg Retina Flowmeter) before and after flicker light stimulation (10 Hz; Photo Stimulater 750). RESULTS: No significant difference was observed in retinal blood flow (RBF) among the three groups, neither at baseline nor after stimulating the retina with flicker light. The arterial wall-to-lumen ratio (WLR) tended to be smaller in Group DM compared with Group C, and was significantly lower when comparing Group IR with Group C. When the subjects were grouped according to their insulin resistance, a steady decline in RBF and WLR could be observed with increasing insulin resistance. CONCLUSIONS: In conclusion, laser scanner flowmetry of the retina was found to detect very early changes in microvascular blood flow. Development of insulin resistance seems to be an important component in the deterioration of RBF.
Authors: T Kawagishi; Y Nishizawa; M Emoto; T Konishi; K Maekawa; S Hagiwara; Y Okuno; H Inada; G Isshiki; H Morii Journal: Diabetes Care Date: 1995-12 Impact factor: 19.112
Authors: S E Bursell; A C Clermont; B T Kinsley; D C Simonson; L M Aiello; H A Wolpert Journal: Invest Ophthalmol Vis Sci Date: 1996-04 Impact factor: 4.799
Authors: G Howard; D H O'Leary; D Zaccaro; S Haffner; M Rewers; R Hamman; J V Selby; M F Saad; P Savage; R Bergman Journal: Circulation Date: 1996-05-15 Impact factor: 29.690
Authors: James S Pankow; David R Jacobs; Julia Steinberger; Antoinette Moran; Alan R Sinaiko Journal: Diabetes Care Date: 2004-03 Impact factor: 19.112
Authors: Christian Ott; Agnes Jumar; Kristina Striepe; Stefanie Friedrich; Marina V Karg; Peter Bramlage; Roland E Schmieder Journal: Cardiovasc Diabetol Date: 2017-02-23 Impact factor: 9.951
Authors: Christine Berndt-Zipfel; Georg Michelson; Markus Dworak; Michael Mitry; Andrea Löffler; Andreas Pfützner; Thomas Forst Journal: Cardiovasc Diabetol Date: 2013-04-08 Impact factor: 9.951